Up 58% in 2026, Is It Too Late to Buy Occidental Petroleum?

OXY is up 58% YTD to $64.36 as of March 26. Valuation is stretched (trailing P/E 47x, forward P/E 20x) but structural moves matter: the OxyChem sale closed Jan 2, 2026 and enabled $5.8B of principal debt reduction to $15.0B, while Q4 2025 adjusted EPS was $0.31 (beat by $0.13) and full-year 2025 operating cash flow was $10.532B. Oil is the key driver—WTI hit $98.71 on March 20 (around $89 on March 23) versus company breakeven near $38/barrel (84% of resources < $50)—a sustained drop to $70–$75/bbl would compress margins and could push the stock toward $55–$58 (consensus target $58.42) or back toward the 50-day at $49.14.

Analysis

Occidental’s move is less about a single accounting event and more about optionality embedded in its balance sheet and operating footprint. Durable deleveraging materially shortens the time horizon for management to pivot from survival-mode capital discipline to active capital returns (buybacks, acceleration of dividends) — that optionality trades like a call on oil and capital allocation, and it is not linear with spot crude. Service and midstream suppliers to the Permian are the quiet beneficiaries: sustained higher realized prices will drive outsized incremental FCF for upstream operators that convert cash quickly, supporting incremental drilling activity and equipment spend over the next 6–18 months.

Key reversals will be macro/oil-driven and can play out on different timelines. Near-term volatility (days–weeks) will be dominated by inventory, SPR releases, and headline geopolitics; medium-term (quarters) by realized differentials, hedging cadence, and the company’s stated buyback cadence; and multi-year outcomes hinge on reserve replacement economics and reinvestment returns. The market is currently compressing two risks — commodity cyclicality and idiosyncratic credit improvement — into a single equity price, which creates opportunities to separate oil exposure from capital-allocation optionality through structuring.

On the margin, the consensus underprices the strategic value transfer to Berkshire from the chemical divestiture: Berkshire now owns a predictable industrial cash flow that smooths its earnings and could accelerate deployment back into cyclical energy or financials when attractive — this reduces the probability of distressed outcomes for the seller and raises the likelihood of continued shareholder-friendly actions. For investors, the decision reduces to a trade between being paid to wait (dividends + buyback optionality) versus needing a favorable oil path; both scenarios are actionable with asymmetric option structures rather than outright directional equity exposure.

Key Decisions for Investors

• Bullish defined-risk: Buy a 9-month OXY call debit spread sized to 2–3% portfolio exposure (cost ~3–6% of notional). Rationale: captures upside from sustained oil and capital-return optionality while limiting premium loss if crude mean-reverts; target 30–50% gross upside on spread, max loss = premium.
• Pair trade to isolate capital-allocation optionality: Long OXY / Short XOM equal-dollar for 6–12 months. Rationale: expresses idiosyncratic debt-improvement & buyback optionality vs diversified major; expected skewed payoff if oil remains firm. Risk: converging commodity exposure could compress spread; size to 1–2% net portfolio beta.
• Downside hedge / tactical short: Buy 3–6 month OXY puts or sell call spreads if shares make new cycle highs without a confirming oil rally. Rationale: volatility spike on crude reversal can erode equity quickly; puts offer convex protection. Target 15–25% downside capture vs premium paid.
• Bank/servicer play: Long WFC 6–12 months (core overweight). Rationale: improved upstream cashflows should reduce energy-related credit volatility and lift NIMs/fee income from energy clients; use a 3–4% position with a 12–18% expected upside versus sector on sustained oil.